DGRA:LSE:LSE-WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc (USD)

ETF | Others |

Last Closing

USD 44.87

Change

+0.08 (+0.17)%

Market Cap

N/A

Volume

2.14K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+13.40 (+7.84%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.04%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.01 (+0.04%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+1.60 (+1.54%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.10 (-1.48%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 259.48B
0QZO:LSE 0QZO

+3.90 (+4.55%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.30 (+0.91%)

USD 202.26B
0R24:LSE Intel Corp.

+1.51 (+7.71%)

USD 196.14B

ETFs Containing DGRA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.76% 32% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.76% 32% F 39% F
Trailing 12 Months  
Capital Gain 7.00% 68% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.00% 64% D 65% D
Trailing 5 Years  
Capital Gain 93.70% 82% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.70% 81% B- 82% B
Average Annual (5 Year Horizon)  
Capital Gain 14.56% 80% B- 79% B-
Dividend Return 14.56% 80% B- 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.48% 54% F 72% C
Risk Adjusted Return 116.73% 96% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike